Aviva Holdings’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,135,966
Closed -$137M 4
2023
Q3
$137M Hold
3,135,966
87.83% 1
2023
Q2
$113M Hold
3,135,966
82.86% 1
2023
Q1
$117M Hold
3,135,966
81.37% 1
2022
Q4
$142M Hold
3,135,966
81.47% 1
2022
Q3
$219M Hold
3,135,966
79.2% 1
2022
Q2
$211M Hold
3,135,966
75.77% 1
2022
Q1
$258M Hold
3,135,966
68.01% 1
2021
Q4
$460M Hold
3,135,966
74.85% 1
2021
Q3
$555M Hold
3,135,966
78.28% 1
2021
Q2
$507M Hold
3,135,966
69.99% 1
2021
Q1
$537M Hold
3,135,966
71.4% 1
2020
Q4
$689M Hold
3,135,966
67.42% 1
2020
Q3
$521M Hold
3,135,966
67.85% 1
2020
Q2
$358M Hold
3,135,966
55.71% 1
2020
Q1
$241M Buy
3,135,966
+275,000
+10% +$21.1M 54.92% 1
2019
Q4
$369M Sell
2,860,966
-275,000
-9% -$35.4M 60.11% 1
2019
Q3
$244M Hold
3,135,966
57.48% 1
2019
Q2
$323M Hold
3,135,966
67.56% 1
2019
Q1
$230M Hold
3,135,966
50.43% 1
2018
Q4
$133M Hold
3,135,966
41.94% 1
2018
Q3
$148M Hold
3,135,966
39.41% 1
2018
Q2
$155M Hold
3,135,966
25.1% 2
2018
Q1
$96.3M Hold
3,135,966
39.06% 2
2017
Q4
$57.2M Buy
3,135,966
+255,264
+9% +$4.66M 33.52% 2
2017
Q3
$33.7M Sell
2,880,702
-1,000
-0% -$11.7K 17.52% 2
2017
Q2
$10.5M Hold
2,881,702
6.63% 3
2017
Q1
$15M Buy
2,881,702
+889,617
+45% +$4.63M 6.99% 2
2016
Q4
$9.46M Hold
1,992,085
9.13% 2
2016
Q3
$13.2M Hold
1,992,085
100% 1
2016
Q2
$10.9M Buy
1,992,085
+446,084
+29% +$2.44M 8.55% 2
2016
Q1
$33.3M Buy
1,546,001
+1,023,501
+196% +$22.1M 23.32% 3
2015
Q4
$16.5M Buy
+522,500
New +$16.5M 18.1% 3